DICLOPHENAC POTASSIUM VERSUS CEPHTAZIDIME FOR REDUCTION OF POST ERCP PANCREATITIS IN AVERAGE RISK PATIENTS-RANDOMISED DOUBLE BLIND CONTROLLED TRIAL

(2) Department of Emergency Medicine,CLINICAL HOSPITAL CENTRE, RIJEKA, CROATIA,Rijeka,Croatia

(3) Department of Gastroenterology and Hepatology,University Clinical Centre Tuzla,Tuzla,Bosnia and Herzegovina

(4) Department of Internal Med., Division of Gastroent,CLINICAL HOSPITAL CENTRE, RIJEKA, CROATIA,Rijeka,Croatia



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)